Venus Remedies Limited — Methotrexate Exporter Profile
Indian Pharmaceutical Exporter · #7 for Methotrexate · $921.0K export value · DGFT Verified
Venus Remedies Limited is the #7 Indian exporter of Methotrexate with $921.0K in export value and 169 verified shipments. Venus Remedies Limited holds a 2.6% market share in Methotrexate exports across 22 countries. The company exports 29 pharmaceutical products worth $86.4M across 6 therapeutic categories.
Venus Remedies Limited — Methotrexate Export Profile: Buyers & Destinations
Where Does Venus Remedies Limited Export Methotrexate?
| Country | Value | Shipments | Share |
|---|---|---|---|
| MOROCCO | $250.2K | 40 | 23.7% |
| SAUDI ARABIA | $243.5K | 64 | 23.1% |
| PERU | $154.1K | 14 | 14.6% |
| COLOMBIA | $121.6K | 16 | 11.5% |
| COSTA RICA | $88.6K | 12 | 8.4% |
| MALAYSIA | $59.6K | 4 | 5.7% |
| THAILAND | $33.8K | 2 | 3.2% |
| LEBANON | $15.4K | 1 | 1.5% |
| VENEZUELA | $13.7K | 5 | 1.3% |
| ALGERIA | $11.4K | 1 | 1.1% |
Venus Remedies Limited exports Methotrexate to 22 countries. The largest destination is MOROCCO accounting for 23.7% of Venus Remedies Limited's Methotrexate shipments, followed by SAUDI ARABIA (23.1%) and PERU (14.6%). These destinations reflect Venus Remedies Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Methotrexate from Venus Remedies Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| P P | MOROCCO | $184.6K | 22 |
| S T C SALEHIYA TRADING | SAUDI ARABIA | $173.6K | 19 |
| SALEHIYA TRADING COMPANY | SAUDI ARABIA | $65.8K | 40 |
| M/S OQCORP S.A.C. | PERU | $59.3K | 5 |
| PROLIFE DE TABACA S.A | COSTA RICA | $56.2K | 9 |
| M.E.L.S.B | MALAYSIA | $44.7K | 2 |
| A.S.A.S | COLOMBIA | $37.6K | 4 |
| PHARMAPROM | MOROCCO | $35.5K | 10 |
| P P L P | THAILAND | $33.8K | 2 |
| O S A C | PERU | $31.1K | 4 |
Venus Remedies Limited supplies Methotrexate to 57 buyers globally. The largest buyer is P P (MOROCCO), followed by S T C SALEHIYA TRADING (SAUDI ARABIA) and SALEHIYA TRADING COMPANY (SAUDI ARABIA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Methotrexate Export Value and How Much Does Venus Remedies Limited Contribute?
India exported $21.3M worth of Methotrexate through 3,806 shipments from 353 suppliers to 148 countries, serving 879 buyers globally. Venus Remedies Limited contributes $921.0K to this total, accounting for 2.6% of India's Methotrexate exports. Venus Remedies Limited ships Methotrexate to 22 countries through 57 buyers.
What Is the Average Shipment Value for Venus Remedies Limited's Methotrexate Exports?
Venus Remedies Limited's average Methotrexate shipment value is $5.4K per consignment, based on 169 shipments totaling $921.0K. The largest destination is MOROCCO (23.7% of Venus Remedies Limited's Methotrexate exports).
How Does Venus Remedies Limited Compare to Other Indian Methotrexate Exporters?
Venus Remedies Limited ranks #7 among 353 Indian Methotrexate exporters with a 2.6% market share. The top 3 exporters are CIPLA LIMITED ($10.8M), EUGIA PHARMA SPECIALITIES LIMITED ($2.9M), INTAS PHARMACEUTICALS LIMITED ($1.5M). Venus Remedies Limited processed 169 shipments to 22 destination countries.
What Methotrexate Formulations Does Venus Remedies Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| METHOTREXATE INJECTION USP (50 MG/2ML) E | $113.5K | 24 |
| METHOTREXATE INJECTION USP 50 MG/2ML EACH ML CONTAINS: METHOTREXATE USP...25 MG | $47.6K | 1 |
| METHOTREXATE INJECTION USP (1000MG/10ML)(TREXOL 1000MG) | $44.7K | 2 |
| METHOTREXATE INJECTION USP 500 MG/5 MLEACH ML CONTAINS:METHOTREXATE USP...100MGB.N.X3IME022A MD.09/2023 ED.08/2025 | $40.3K | 1 |
| METHOTREXATE INJECTION USP (500 MG/5 ML). TREXIMED 500 MG. B.NO.X5CME012A,X5CME022A MD.03/2025, ED.02/2027 | $28.3K | 1 |
| METHOTREXATE INJECTION USP (50 MG/2ML) EACH ML CONTAINS: METHOTREXATE USP...25 MG, WATER FOR INJECTION USP...Q.S | $28.3K | 3 |
| METHOTREXATE INJECTION USP 500 MG 5 ML TREXIMED 500 MG B NO X5CME012A X5CME022A MD 03 2025 ED 02 2027 | $27.4K | 1 |
| METHOTREXATE INJECTION USP (500 MG/5 ML) | $23.6K | 8 |
| METHOTREXATE INJECTION USP (500 MG/5 ML)TREXIMED 500 MG BN.X4CME032B,X4CME042A,X4CME052A MD.03/2024,ED.02/2026 | $22.2K | 1 |
| METHOTREXATE INJECTION USP (50 MG/2ML) EACH ML CONTAINS: METHOTREXATE USP...25 MG, (ALPHATREX 50MG) | $20.7K | 1 |
Venus Remedies Limited exports 140 distinct Methotrexate formulations including tablets, capsules, syrups, and combination drugs. The top formulation is METHOTREXATE INJECTION USP (50 MG/2ML) E with 24 shipments worth $113.5K.
How Does Venus Remedies Limited Compare to Nearest Methotrexate Exporters?
Exporters ranked immediately above and below #7 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 6 | NAPROD LIFE SCIENCES PRIVATE LIMITED | $1.2M | 45 | 8 | $25.6K |
| 4 | ZYDUS LIFESCIENCES LIMITED | $950.0K | 19 | 2 | $50.0K |
| 7 | VENUS REMEDIES LIMITED ★ | $921.0K | 169 | 22 | $5.4K |
| 8 | FRESENIUS KABI ONCOLOGY LIMITED | $771.5K | 101 | 15 | $7.6K |
| 5 | ALEMBIC PHARMACEUTICALS LIMITED | $600.0K | 12 | 1 | $50.0K |
Venus Remedies Limited ranks #7 among 353 Indian Methotrexate exporters. Average shipment value of $5.4K compared to the market average of $60.3K. The closest competitors by value are NAPROD LIFE SCIENCES PRIVATE LIMITED and ZYDUS LIFESCIENCES LIMITED.
Which Indian Ports Ship Methotrexate Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR | 890 | 23.4% |
| SAHAR AIR CARGO ACC (INBOM4) | 719 | 18.9% |
| DELHI AIR CARGO ACC (INDEL4) | 415 | 10.9% |
| DELHI AIR | 267 | 7.0% |
| Bombay Air | 239 | 6.3% |
| NHAVA SHEVA SEA (INNSA1) | 148 | 3.9% |
| HYDERABAD AIR | 89 | 2.3% |
| Bombay Air Cargo | 80 | 2.1% |
Geopolitical & Trade Policy Impact on Venus Remedies Limited's Methotrexate Exports
The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like Venus Remedies. The ongoing Israel-Iran tensions have led to disruptions in Red Sea shipping routes, increasing transit times and costs for exports to Europe and the Americas. Such disruptions necessitate strategic adjustments in logistics and supply chain management to maintain timely deliveries and cost-effectiveness.
Conversely, the U.S.-China trade tensions have opened avenues for Indian pharmaceutical companies to strengthen their presence in the U.S. market. India now supplies 40% of the U.S.'s generic drug needs, reflecting a growing reliance on Indian manufacturers. (ibef.org) Venus Remedies' recent QIDP designation from the U.S. FDA for VRP-034 positions the company favorably to leverage this opportunity, potentially enhancing its market share in the U.S.
In the European Union, compliance with the Falsified Medicines Directive (FMD) remains critical. Venus Remedies' renewal of the EU-GMP certification indicates their proactive approach to meeting stringent EU regulations, thereby ensuring continued access to European markets. (business-standard.com)
Venus Remedies Limited — Regulatory Compliance & Quality Standards
Maintaining compliance with international regulatory standards is paramount for pharmaceutical exporters. Venus Remedies has demonstrated a consistent commitment to quality, as evidenced by multiple GMP certifications. In addition to the EU-GMP renewal, the company secured GMP certification from Moldova's Ministry of Health in January 2025, covering their antibiotic-carbapenem manufacturing facility. (apnnews.com) Furthermore, the renewal of Ukrainian GMP certification in May 2025 for their Baddi facility underscores their adherence to global quality standards. (apnnews.com)
These certifications not only facilitate market access but also enhance the company's reputation as a reliable supplier of high-quality pharmaceuticals. In an industry where regulatory compliance is closely scrutinized, Venus Remedies' proactive measures position them favorably among global competitors.
About Venus Remedies Limited
Venus Remedies Limited exports 29 products worth $86.4M. Beyond Methotrexate, top products include Meropenem, Imipenem, Enoxaparin, Ceftriaxone, Paclitaxel. View the complete Venus Remedies Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Methotrexate — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Methotrexate shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Venus Remedies Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 190 individual customs records matching Venus Remedies Limited exporting Methotrexate, covering 140 formulations to 22 countries via 57 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 148+ countries, 879+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Methotrexate Export Data from Venus Remedies Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Venus Remedies Limited's Methotrexate exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Venus Remedies Limited
Full Company Profile →
29 products · $86.4M total trade · 6 categories
Methotrexate Stats
Company Overview
Top Products by Venus Remedies Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Venus Remedies Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Methotrexate. For current shipment-level data, contact TransData Nexus.